Showing results (141-150 of 212) with videos related to
Sort By:
Pageof 22
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomasTove Olafsen, David Betting, Vania E Kenanova, et al.Molecular Cancer Therapeutics|January 28, 2022
89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma ModelKirstin A Zettlitz, Felix B Salazar, Reiko E Yamada, et al.Cancer Biotherapy & Radiopharmaceuticals|August 17, 2010
A pretherapy biodistribution and dosimetry study of indium-111-radiolabeled trastuzumab in patients with human epidermal growth factor receptor 2-overexpressing breast cancerJeffrey Y C Wong, Andrew Raubitschek, Dave Yamauchi, et al.Cancer Research|February 21, 2006
Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugatesChe-Leung Law, Kristine A Gordon, Brian E Toki, et al.Molecular Cancer Therapeutics|November 17, 2017
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid LeukemiaFu Li, May Kung Sutherland, Changpu Yu, et al.Molecular Cancer Therapeutics|October 28, 2024
Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47Matthew R Levengood, Christopher M Carosino, Xinqun Zhang, et al.Current Organic Synthesis|September 15, 2012
Molecular Imaging Probe Development using MicrofluidicsKan Liu, Ming-Wei Wang, Wei-Yu Lin, et al.Cancer Research|November 18, 2015
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to ImmunotherapyRichard Tavaré, Helena Escuin-Ordinas, Stephen Mok, et al.Medical Physics|February 6, 2015
Characterization of a double-sided silicon strip detector autoradiography systemAnders Örbom, Jonas Ahlstedt, Tom Serén, et al.Bioconjugate Chemistry|July 2, 2013
A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technologyScott C Jeffrey, Patrick J Burke, Robert P Lyon, et al.Pageof 22